Cardio Diagnostics Holdings Inc. Warrant (CDIOW) Stock Price
CDIOWStock
$0.02
Market Cap—
P/E—
PEG Ratio—
Div yield—
Beta1.41
CDIOW Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-38.18%
Price vs S&P 500 (4W)36.74%
VGM Score64.78
Industry Peers — In Vitro Diagnostics(18)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
CDIOWCardio Diagnostics Holdings Inc. Warrant | — | — | B | $0.02 |
| IDXXIdexx Laboratories Inc | D | B | C | $554.99 |
| LNTHLantheus Holdings, Inc | C | B | B | $100.77 |
| CLDXCelldex Therapeutics, Inc | F | F | B | $39.12 |
| NEOGNeogen Corp | C | C | B | $11.66 |
| NTLAIntellia Therapeutics, Inc | D | D | C | $12.87 |
| QDELQuidelOrtho Corporation Common Stock | C | C | C | $14.74 |
| ACHVAchieve Life Sciences, Inc. | F | F | A | $8.10 |
| TKNOAlpha Teknova, Inc. Common Stock | D | C | B | $7.12 |
| NNNNAnbio Biotechnology Class A Ordinary Shares | F | B | F | $7.67 |
| MYGNMyriad Genetics Inc | B | C | D | $3.16 |
About Cardio Diagnostics Holdings Inc. Warrant
Cardio Diagnostics Holdings develops AI-powered epigenetic blood tests for detecting and assessing coronary heart disease risk. The company's product suite includes Epi+Gen CHD for symptomatic risk assessment, PrecisionCHD for CHD detection, and Actionable Clinical Intelligence, a platform that delivers personalized patient insights by analyzing epigenetic and genetic biomarkers. These solutions aim to improve cardiovascular disease management and patient outcomes through advanced diagnostic capabilities.